Literature DB >> 3305558

Evaluation of passive particle agglutination test for antibody to human immunodeficiency virus.

T Yoshida, T Matsui, S Kobayashi, N Yamamoto.   

Abstract

A gelatin particle agglutination assay was compared with indirect immunofluorescence by using 663 serum samples from acquired immunodeficiency syndrome and acquired immunodeficiency syndrome-related complex patients and asymptomatic male homosexuals in the United States and from hemophiliacs and healthy adult controls in Japan. The results showed that all 104 samples which were positive by indirect immunofluorescence were also positive by particle agglutination, while 5 additional samples were positive by particle agglutination only. The coincidence rate for antibody-positive and antibody-negative specimens was 99% (658 of 663) between particle agglutination and immunofluorescence. Four of the five samples which were positive by particle agglutination only were found by radioimmunoprecipitation to contain anti-env gene products of human immunodeficiency virus. Antibody titers of samples giving a positive reaction by particular agglutination varied from low (titer, 256) to remarkably high (256 X 10(5)). All specimens having particle agglutination titers of more than 10(5) were positive by immunofluorescence. A high correlation (r = 0.66) was observed between the titers of antibodies determined by particle agglutination and those determined by immunofluorescence. After fractionation of a serum sample from an individual at high risk by using high-performance liquid chromatography, it was shown that immunoglobulin M as well as immunoglobulin G human immunodeficiency virus antibody was detected by particle agglutination. Additional serum samples with a potential risk of giving false-positive results, such as heat-treated specimens, specimens containing antibodies to HLA, specimens containing auto-antibodies, and serum samples from individuals with a history of multiple blood transfusions, were shown to be clearly negative by particle agglutination.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305558      PMCID: PMC269241          DOI: 10.1128/jcm.25.8.1433-1437.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Prevalence of possible adult T-cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide study.

Authors:  Y Maeda; M Furukawa; Y Takehara; K Yoshimura; K Miyamoto; T Matsuura; Y Morishima; K Tajima; K Okochi; Y Hinuma
Journal:  Int J Cancer       Date:  1984-06-15       Impact factor: 7.396

2.  Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.

Authors:  Y Hinuma; H Komoda; T Chosa; T Kondo; M Kohakura; T Takenaka; M Kikuchi; M Ichimaru; K Yunoki; I Sato; R Matsuo; Y Takiuchi; H Uchino; M Hanaoka
Journal:  Int J Cancer       Date:  1982-06-15       Impact factor: 7.396

3.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Authors:  M G Sarngadharan; M Popovic; L Bruch; J Schüpbach; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

4.  Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome.

Authors:  P M Feorino; V S Kalyanaraman; H W Haverkos; C D Cabradilla; D T Warfield; H W Jaffe; A K Harrison; M S Gottlieb; D Goldfinger; J C Chermann
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

5.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line.

Authors:  N Yamamoto; M Okada; Y Koyanagi; M Kannagi; Y Hinuma
Journal:  Science       Date:  1982-08-20       Impact factor: 47.728

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  9 in total

1.  Comparative assessment of the gelatin particle agglutination test and an enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis.

Authors:  J Sithithaworn; P Sithithaworn; T Janrungsopa; K Suvatanadecha; K Ando; M R Haswell-Elkins
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

2.  Performance and cost-effectiveness of a dual rapid assay system for screening and confirmation of human immunodeficiency virus type 1 seropositivity.

Authors:  F A Spielberg; C M Kabeya; T C Quinn; R W Ryder; N K Kifuani; J Harris; T R Bender; W L Heyward; M R Tam; K Auditore-Hargreaves
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

3.  Simplified testing for antibodies to human immunodeficiency virus.

Authors:  P Pagcharoenpol; A Burgess-Cassler; W Schramm
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

4.  Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa.

Authors:  S Aidoo; W K Ampofo; J A Brandful; S V Nuvor; J K Ansah; N Nii-Trebi; J S Barnor; F Apeagyei; T Sata; D Ofori-Adjei; K Ishikawa
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

5.  Development of a particle agglutination method with soluble virus receptor for identification of poliovirus.

Authors:  Minetaro Arita; Souji Masujima; Takaji Wakita; Hiroyuki Shimizu
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

6.  Agreement study between two laboratories of immunofluorescence as a confirmatory test for human immunodeficiency virus type 1 antibody screening.

Authors:  J Mahony; K Rosenthal; M Chernesky; S Castriciano; E Scheid; M Blajchman; D Harnish
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

7.  Evaluation of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus.

Authors:  H Arai; B Petchclai; K Khupulsup; T Kurimura; K Takeda
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

8.  Comparative studies of commercially available particle agglutination assay and enzyme-linked immunosorbent assay for screening of human T-cell leukemia virus type I antibodies in blood donors.

Authors:  S Kobayashi; T Yoshida; Y Hiroshige; T Matsui; N Yamamoto
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

Review 9.  Differential diagnosis of human retrovirus infections in the laboratory.

Authors:  B P Griffith
Journal:  Yale J Biol Med       Date:  1989 Mar-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.